Companies: 10,795·Total market cap: $144.5T

Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc.

APVONASDAQHealthcare● Active

$4.89

+$0.17(+3.60%)

Market Cap$10693731

P/E Ratio—

52W High$235.98

52W Low$3.8

Avg Volume57K

Open$4.80

Beta1.69

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Aptevo Therapeutics Inc.（APVO）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · APVO · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-357.16Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding3,155Shares outstanding history

Next EarningsAug 10, 2026Est.Earnings history

探索 Aptevo Therapeutics Inc. 数据

分析师预测$— · Buy

股息不分红

盈利EPS $-87.27+99.72%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$26.0M▼ 7.61% YoY

202320242025

FY 2025EPS$-87.27▲ +99.72% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$26.3MEPS: $-357.16View income statement →

分析师评级与目标价

Buy3 位分析师

Strong Buy

0

Buy

3

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$4.89Current

$—Avg Target

$—High

合计: 3 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Aptevo Therapeutics Inc.

$4.89+3.60%$10.7M #2

Abpro Corporation

$0.52+0.00%$1.1M #3

BioCardia, Inc.

$0.92-10.68%$5.3M #4

CERo Therapeutics Holdings, Inc.

$0.01-13.64%$12,596 #5

ESSA Pharma Inc.

$0.20-1.85%$9.5M #6

Ernexa Therapeutics Inc.

$7.54-4.44%$2.4M

股票表现

1D+3.60%

1W-7.91%

1M-1.61%

3M-23.59%

YTD-48.14%

1Y-94.20%

5Y-100.00%

关于 Aptevo Therapeutics Inc.

CEOJeffrey G. Lamothe

IPO DateJul 20, 2016

Employees37

CountryUS

Websiteaptevotherapeutics.com

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company primarily focused on pioneering immunotherapeutic agents for a variety of cancer treatments across the United States. Its foremost in…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Aptevo Therapeutics Inc.（APVO）是 Biotechnology 行业的 Healthcare 类公司，于 Jul 20, 2016 在 NASDAQ 上市。截至最近交易日，APVO 股价为 $4.89，市值约为 $10.7M。过去12个月累计回报 -94.20%，年初至今回报 -48.14%。

根据 3 位华尔街分析师，Aptevo Therapeutics Inc. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 Aptevo Therapeutics Inc. 营收 —，净利润 -$26.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Aptevo Therapeutics Inc.（APVO）股价为 $4.89，在 NASDAQ 上市，52周区间为 $3.80 – $235.98。

APVO 最新股价APVO quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议